Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers

CONCLUSIONS: Both intra- and interpatient drug response heterogeneity exist in patients undergoing CRS/HIPEC for nongynecologic abdominal cancers. Caution must be used when interpreting patient response to chemotherapeutic agents based on a single site of testing in those with metastatic disease.PMID:38175427 | DOI:10.1245/s10434-023-14696-6

Source: Ann Oncol - January 4, 2024 Category: Cancer & Oncology Authors: Shannon N Radomski Matthew Dunworth Junior J West Jonathan B Greer Fabian M Johnston Andrew J Ewald Source Type: research